Title:
第Ｘａ因子阻害剤の結晶性塩
Document Type and Number:
Japanese Patent JP5796872
Kind Code:
B2
Abstract:
The present invention provides salts and crystalline forms of the compound 5-chloro-N-((1-(4-(2-oxopyridin-1(2H)-yl)phenyl)-1H-imidazol-4-yl)methyl)thiophene-2-carboxamide, and pharmaceutical compositions and method of use thereof.
Inventors:
Pandy, anjaly
Kuegen, Louisa Jane
Kuegen, Louisa Jane
Application Number:
JP2012544856A
Publication Date:
October 21, 2015
Filing Date:
December 16, 2010
Export Citation:
Assignee:
MILLENNIUM PHARMACEUTICALS, INC.
International Classes:
C07D409/14; A61K31/4439; A61P7/02; A61P9/00; C07C65/11; C07C303/44; C07C309/04
Domestic Patent References:
| JP2009536218A |
Other References:
Journal of Pharmaceutical Sciences,1977年,Vol.66, No.1,p.1-19
GOULD Philip L.,Salt selection for basic drugs,International Journal of Pharmaceutics,1986年,Vol.33,pp.201-217
平山令明,有機化合物結晶作製ハンドブック,2008年,p.17-23,37-40,45-51,57-65
医薬品の残留溶媒ガイドラインについて,1998年,第1~11頁
GOULD Philip L.,Salt selection for basic drugs,International Journal of Pharmaceutics,1986年,Vol.33,pp.201-217
平山令明,有機化合物結晶作製ハンドブック,2008年,p.17-23,37-40,45-51,57-65
医薬品の残留溶媒ガイドラインについて,1998年,第1~11頁
Attorney, Agent or Firm:
Hidesaku Yamamoto
Takaaki Yasumura
Natsuki Morishita
Takaaki Yasumura
Natsuki Morishita